Dimensional Fund Advisors LP Inovio Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.38 - $0.58 $2,997 - $4,574	-7,887 Reduced 10.82%	65,024 $25,000
Q2 2023 Aug 09, 2023	SELL	$0.39 - $0.94 $266,541 - $642,432	-683,439 Reduced 90.36%	72,911 $32,000
Q1 2023 May 12, 2023	SELL	$0.79 - $1.91 $148,468 - $358,955	-187,935 Reduced 19.9%	756,350 $620,000
Q4 2022 Feb 09, 2023	BUY	$1.41 - $2.5 $1.08 Million - $1.91 Million	765,721 Added 428.82%	944,285 $1.47 Million
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $296,416 - $498,193	178,564 New	178,564 $308,000
Q2 2022 Aug 12, 2022	SELL	$1.44 - $3.98 $22,260 - $61,526	-15,459 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $7,546 - $13,213	-2,541 Reduced 14.12%	15,459 $55,000
Q4 2021 Feb 09, 2022	SELL	$4.99 - $7.46 $66,371 - $99,225	-13,301 Reduced 42.49%	18,000 $90,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $74,779 - $101,202	10,444 Added 50.07%	31,301 $224,000
Q2 2021 Aug 12, 2021	BUY	$6.23 - $10.03 $129,939 - $209,195	20,857 New	20,857 $193,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.